Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York-Reference-Cited by-同舟云学术

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

Published:2020-07-02 Issue:1 Volume:383 Page:85-88
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Haberman Rebecca,Axelrad Jordan,Chen Alan¹,Castillo Rochelle,Yan Di,Izmirly Peter,Neimann Andrea,Adhikari Samrachana¹,Hudesman David,Scher Jose U.^ORCID

Affiliation:

1. New York University Grossman School of Medicine, New York, NY

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2009567

Cited by 359 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review;American Journal of Medicine Open;2024-06

2. Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials;British Journal of Dermatology;2024-01-16

3. Hospitalization, disease severity and mortality rates of patients with inflammatory rheumatic diseases as compared with the normal population in the second wave of SARS-CoV-2 infections;Rheumatology;2023-12-06

4. Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial;Biomedicine & Pharmacotherapy;2023-12

5. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase;Journal of Translational Autoimmunity;2023-12